biote Corp.

biote Corp., which trades under the ticker HYAC, completed its business combination with Haymaker Acquisition Corp. II, a blank-check company sponsored by Haymaker Group and led by Andrew Heyer. The SPAC conducted its initial public offering in 2021, targeting the healthcare sector, and subsequently merged with biote Corp., a hormone optimization company offering subcutaneous pellet therapy products and practitioner training services to medical providers across the United States. The company has been active in SEC reporting, including this 8-K filing dated May 14, 2025, accession number 0001193125-25-119861, reflecting its continued status as a post-combination public reporting company. Sign up at SpacDesk for full filing history, sponsor details, and deal analytics on biote and hundreds of other SPAC transactions.